Clinical Trial: MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis With Special Focus on Patient Satisfaction

Brief Summary: Desmopressin in treatment of nocturnal enuresis (bedwetting).

Detailed Summary:
Sponsor: Ferring Pharmaceuticals

Current Primary Outcome: Assessment of patient and parent satisfaction [ Time Frame: 3 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Number of wet nights [ Time Frame: 3 months ]
  • Assessment of drinking volume [ Time Frame: 3 months ]
  • Assessment of urine volume [ Time Frame: 3 months ]
  • Assessment of patient compliance [ Time Frame: 3 months ]


Original Secondary Outcome: Same as current

Information By: Ferring Pharmaceuticals

Dates:
Date Received: June 7, 2011
Date Started: June 2011
Date Completion:
Last Updated: June 11, 2013
Last Verified: June 2013